Abstract: The present invention relates to a sustained release drug delivery system composed of a water insoluble polymer, and more particularly, to a sustained release drug delivery system comprising: a crystalline core material; an active ingredient layer which is formed on an outer surface of the crystalline core material and comprises a pharmacologically active ingredient and a water insoluble polymer; and a sustained release layer which is formed on an outer surface of the active ingredient layer and comprises a sustained release film forming material. The present invention also relates to a sustained release drug delivery system which releases an effective drug in an aqueous solution or a body fluid for 24 hours by using a sustained release film forming material and a plasticizer together to provide sustained release of a pharmacologically active ingredient.

Abstract: A poison bait in the form of gel which comprises an active ingredient for controlling wood harmful insect, water and cellulose ether has an excellent efficacy for controlling wood harmful insects, wherein the content ratio of water:the cellulose ether is 4:1 to 3:4.

Abstract: The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the formula (I) and active compounds identified in the disclosure.

Abstract: The invention relates to new 2,2,3,3-tetramethylcyclopropane carboxamide derivative compounds, pharmaceutical compositions thereof and uses thereof for treating psychotic disorders, neurodegenerative diseases, epilepsy and pain.

Abstract: A pesticidal composition comprising a pesticidally effective amount of at least one of a pyridic compound of the formula (I) or it salt and at least one of other pesticides: wherein Y is a haloalkyl group, m is 0 or 1, and Q is or a substituted or unsubstituted heterocyclic group, (wherein X is an oxygen atom or a sulfur atom, R1 and R2 are respectively independently a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted cycloalkyl group, and the like.

Abstract: The invention relates to compounds of the formula I in which the radicals are defined as specified, and also to their physiologically tolerated salts. The compounds are suitable, for example, as medicaments for preventing and treating type 2 diabetes.

Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.

Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.

Abstract: Termites can be controlled by applying a composition comprising N-(2,6-difluorobenzoyl)-N′-[2 -chloro-3,5-bis(trifluoromethyl)phenyl]urea and dried yeast.

Abstract: In one aspect, the present invention provides a method for modulating an Edg-2 receptor mediated biological activity in a cell. A cell expressing the Edg-2 receptor is contacted with an modulator of the Edg-2 receptor, which modulates the Edg-2 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating Edg-2 receptor mediated biological activity in a subject. A therapeutically effective amount of an modulator of the Edg-2 receptor is administered to the subject.

Abstract: In one aspect, the present invention provides a method of inhibiting an Edg-3 receptor mediated biological activity in a cell. A cell expressing the Edg-3 receptor is contacted with an amount of an Edg-3 receptor inhibitor sufficient to inhibit the Edg-3 receptor mediated biological activity. Preferably, the inhibitor is not a phospholipid.

Abstract: The invention relates to heterocyclically substituted benzoylureas and also to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory diseases, immunological diseases and cancer.

Abstract: The invention relates to urea- and urethane-substituted acylureas and to their physiologically tolerated salts and physiologically functional derivatives.

Abstract: A class of compounds is described which can be used for the treatment of viral infections.

Abstract: Compounds of the formula (I), in which M is a central building block selected from the group below in which Al, A2, K1 and K2 are as defined in the description, are novel effective tryptase inhibitors.

Abstract: The present invention is directed to new compositions of matter comprising the reaction products of a carboxylic acid and a urea having the formula: where R1, R2, R3 and R4 are the same or different and are selected from the group consisting of hydrogen, substituted and unsubstituted alkyl, allyl, vinyl and alkoxyl groups having from 1-6 carbon atoms, substituted and unsubstituted phenyl groups and the halides. Preferably, the reaction product of the present invention is N,N′-diformylurea or N,N′-diacetylurea. These reaction products, e.g., diformylurea, have been found to produce significantly improved growth in a variety of agricultural products when applied to the seed, to the surrounding soil or to the foliage of the emerging plant. Because of the similarity in the carbon, nitrogen, oxygen structure of these reaction products with many biological compounds, it is believed that the reaction products of the present invention may find use in a variety of biological applications.

Abstract: The present invention is directed to a new class of serotonin 5HT2 antagonists and thier use in the treatment of a variety of diseases.

Abstract: Monoacyl-substituted guanidines of formula III, or a salt or acid thereof, and their use as medicine or diagnostic aid: in which X(2) is

Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives.

Abstract: Termites can be controlled by applying an effective amount of N-[2-chloro-3,5-bis(trifluoromethyl)phenyl]-N′-(2,6-difluorobenzoyl)urea supported on cellulose.

Abstract: A method of successfully controlling sea lice in commercial fish farming, in an efficient and environmentally friendly way, with the compounds named in claim 1, preferably by injection, and a method of automating this type of control, are described.

Abstract: There is now described a method of controlling pests with pymetrozine, profenofos, a benzoylurea-derivative or a carbamat-derivative; more specifically a method of controlling pests in and on transgenic crops of useful plants, such as, for example, in crops of maize, cereals, soya beans, tomatoes, cotton, potatoes, rice and mustard, with pymetrozine, profenofos, a benzoylurea-derivative, especially lufenuron; or a carbamat-derivative, especially fenoxycarb; characterized in that a pesticidal composition comprising pymetrozine, profenofos, a benzoylurea-derivative or a carbamat-derivative, in free form or in agrochemically useful salt form and at least one auxiliary is applied to the pests or their environment, in particular to the crop plant itself.

Abstract: A veterinary preparation for fleas is described, which consists of an amount that is effective against fleas of a combination of a compound of formula (I), wherein R1 hydrogen, C1-C6-alkyl or C3-C7-cycloalkyl; R2 is hydrogen, C1-C6-alkyl or C3-C7-cycloalkyl; R3 is hydrogen or C1-C6-alkyl; and A is heterocycly which is unsubstituted or substituted once or repeatedly by identical or different halogen atoms; and a compound of formula (II), wherein X is halogen, X1 is hydrogen or halogen; X2 is hydrogen or halogen; Y is partially or completely halogenated C1-C6-alkoxy, or partially or completely halogenated C1-C6-alkoxy which is interrupted by one oxygen atom, or partially or completely halogenated C2-C6-alkenyl; Y1 is hydrogen or halogen; Y2 is hydrogen or halogen; Y3 is hydrogen or halogen; Z1 is hydrogen or C1-C3-alkyl; and Z2 is hydrogen or C1-C3-alkyl; and a physiologically acceptable formulation excipient.

Abstract: The invention relates to use of (a) compounds of phosphorus containing at least partly lipophilic organic radicals together with (b) urea and/or urea derivatives in selected quantity ratios of (a) to (b) as a soil additive for biologically controlling plant-parasitic soil nematodes by strengthening the correspondingly antagonistic soil potential, more particularly by strengthening the growth of antagonistic and/or nematicidal rhizosphere bacteria and/or corresponding mycorrhiza strains—and at the same time strengthening the growth of cultivated plants in soil. The multicomponent mixtures which strengthen bacterial growth are preferably introduced into the region of the plant roots in the form of an aqueous preparation using plant-compatible emulsifiers before and/or during plant growth. Components (a) and (b) are used in such quantity ratios that the ratio by weight of C to N is no higher than 6:1 and preferably no higher than 5:1.

Abstract: Glucokinase activating compounds of the formula wherein R1 and R2 are independently hydrogen, halo, amino, nitro, cyano, sulfonamido, lower alkyl, perfluoro-lower alkyl, lower alkyl thio, perfluoro-lower alkyl thio, lower alkyl sulfonyl, or perfluoro-lower alkyl sulfonyl; R3 is cycloalkyl having from 3 to 7 carbon atoms or lower alkyl having from 2 to 4 carbon atoms; R4 is hydrogen, lower alkyl, lower alkenyl, hydroxy lower alkyl, halo lower alkyl, R5 and R6 are hydrogen or lower alkyl; and n is 0, 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof

Abstract: The invention is directed to acylphenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and their physiologically tolerated salts and a process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.

Abstract: Diacyl-substituted guanidines of the formula I are described where X(1) and X(2) are as defined herein. The compounds are suitable for use as antiarrhythmic pharmaceuticals possessing a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris, in connection with which they also inhibit or strongly reduce, in a preventitive manner the pathophysiological processes associated with the genesis of ischemically induced damage, in particular associated with the elicitation of ischemically induced cardiac arrhythmias.

Abstract: An improved termite bait composition comprises a powdered cellulosic attractant having a particle size in the range of approximately 1 to 100 micrometers and a termite killing agent. Also disclosed are a method for controlling termites by applying the termite bait composition to a termite infested area and a termite bait composition package for use in a termite bait station comprising the termite bait composition contained within a termite attractive package.

Abstract: A veterinary preparation for fleas is described, which consists of an amount that is effective against fleas of a combination of a compound of formula (I), wherein R1 hydrogen, C1-C6-alkyl or C3-C7-cycloalkyl; R2 is hydrogen, C1-C6-alkyl or C3-C7-cycloalkyl; R3 is hydrogen or C1-C6-alkyl; and A is heterocycly which is unsubstituted or substituted once or repeatedly by identical or different halogen atoms; and a compound of formula (II), wherein X is halogen, X1 is hydrogen or halogen; X2 is hydrogen or halogen; Y is partially or completely halogenated C1-C6-alkoxy, or partially or completely halogenated C1-C6-alkoxy which is interrupted by one oxygen atom, or partially or completely halogenated C2-C6-alkenyl; Y1 is hydrogen or halogen; Y2 is hydrogen or halogen; Y3 is hydrogen or halogen; Z1 is hydrogen or C1-C3-alkyl; and Z2 is hydrogen or C1-C3-alkyl; and a physiologically acceptable formulation excipient.

Abstract: The present invention relates to an ant or yellow jacket bait that is particularly effective for controlling carpenter ants. The bait is comprised mostly of sugars in a viscous and fluid form that may be readily dispensed into an ant station at room temperatures, and provides a moist, sweet surface that is attractive to ants.

Abstract: The present invention provides new methods for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine. Furthermore, new methods are described for the treatment and prevention of hepatic disorders involving the use of 2,6-di-tert-butylphenol derivatives.

Abstract: Controlled release compositions of matter are disclosed comprising complexes for treating a population of one or more aquatic organisms in a column of water. The complexes comprise at least one system wherein the system comprises at least one bioactive agent as a component selected for treating a population of aquatic organisms, at least one carrier component, and at least one coating component for regulating the controlled release rate and release profile of the bioactive agent in water or at least one bioactive agent and one joint-function component that can serve as both a carrier and coating to regulate the controlled release rate and release profile of the bioactive agent in water, with or without optional binder components and/or additional formulation materials. The components are selected to sink or float so that the complexes will permeate and/or remain in any planar or volumetric segment of a water column for a period of time that is sufficient to effectively treat a population of aquatic organisms.

Abstract: The present invention provides a method to control ecto-parasites of a host animals wherein 1-(2,6-difluorobenzoyl)-3-[2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]urea is applied to the said host animals. By the method of the present invention, ecto-parasites of animals can be controlled effectively for a long period of time.

Abstract: The present invention provides a method to control ecto-parasites of a host animals wherein 1-(2,6-difluorobenzoyl)-3-[2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]urea is applied to the said host animals.

Abstract: A method of lowering plasma levels of &agr;-dicarbonyl precursors of advanced alycation end products such as methylglyoxal in a patient having type 2 diabetes by administrating metformin in a dosage at least twenty five percent in excess of its antidiabetic therapeutic regimen for the patient is provided. The high dosage of metformin acts to reduce plasma levels of &agr;-dicarbonyl compounds by a mechanism distinct from that whereby it exerts its antidiabetic activity.

Abstract: Compounds of the formula (I) wherein R1 and R2 are H, methyl, or ethyl, provided that at least one of R1 or R2 is methyl or ethyl, have unexpected activity against ants. Compounds wherein at least one of R1 and R2 is methyl or ethyl are novel.

Abstract: The present invention relates to new active compound combinations of pyrethroids with insect development inhibitors, for achieving a long-term effect against animal pests with high effectiveness, fewer environmentally polluting properties and a toxicologically favourable control concept.

Abstract: The present invention relates to an ant or yellow jacket bait that is particularly effective for controlling carpenter ants. The bait is comprised mostly of sugars in a viscous and fluid form that may be readily dispeised into an ant station at room temperatures, and provides a moist, sweet surface that is attractive to ants.

Abstract: Compounds of the formula (I) wherein R1 and R2 are H, methyl, or ethyl, have unexpected activity against ants. Compounds wherein at least one of R1 and R2 is methyl or ethyl are novel.

Abstract: Compounds of the formula (I) wherein R1 and R2 are H, methyl, or ethyl, have unexpected activity against cockroaches. Compounds wherein at least one of R1 and R2 is methyl or ethyl are novel.

Abstract: A fungicidal mixture comprisinga) an oxime ether of the formula I ##STR1## where the substituents have the following meaning: X is oxygen or amino (NH);Y is CH or N;Z is oxygen, sulfur, amino (NH) or C.sub.1 -C.sub.4 -alkylamino (N--C.sub.1 -C.sub.4 -alkyl);R' is C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -haloalkyl, C.sub.3 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -haloalkenyl, C.sub.3 -C.sub.6 -alkynyl, C.sub.3 -C.sub.6 -haloalkynyl, C.sub.3 -C.sub.6 -cycloalkylmethyl, or benzyl which may be partially or fully halogenated and/or may carry one to three of the following radicals: cyano, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -haloalkyl, C.sub.1 -C.sub.4 -alkoxy, C.sub.1 -C.sub.4 -haloalkoxy and C.sub.1 -C.sub.

Abstract: The present invention provides a pharmaceutical or veterinary composition comprising, a carrier and an active ingredient being a compound of the following formula I: ##STR1## wherein R.sup.1 and R.sup.2 are each independently hydrogen, halogen or methoxy, as well as salts of the compound of formula I.Further provided by the invention is a method of treatment of fungal infection, comprising administering to a patient in need, an effective amount of the compound of said formula I.

Abstract: Combinations of a chitin synthesis inhibitor (e.g. hexaflumuron, flufenoxuron, lufenuron, and dimiin) with a juvenile hormone mimic (e.g. methoprene and pyriproxyfen) afford synergistic activity against termites.

Abstract: A method for controlling insects of Lepidoptera on a genetically altered cotton plant having incorporated therein a gene derived from Bacillus thuringiensis (Bt) which codes for and expresses a protein having pesticide activity comprising the steps of applying to the foliage of said genetically altered cotton plant a pesticidally active amount of certain substituted benzoyl urea compounds.

Abstract: A pesticidal combination comprising a compound of formula (I) and a 1-arylpyrazole of formula (II).

Abstract: Compounds of formula (I): ##STR1## wherein R.sup.1 is H or F and R.sup.2 is CF.sub.3 or CF.sub.2 CF.sub.3, exhibit unexpectedly superior activity against cockroaches and are also useful to control other insects.

Abstract: Compounds of the formula (I) ##STR1## wherein R.sup.1 and R.sup.2 are H, methyl, or ethyl, have unexpected activity against fleas. Compounds wherein at least one of R.sup.1 and R.sup.2 is methyl or ethyl are novel.

Abstract: The present invention relates to a novel benzoyl urea derivative which exhibits potent growth-retarding activity against pests and which is represented by formula (I), ##STR1## in which A represents N or CH, and X.sup.1 and X.sup.2 independently of one another represent hydrogen, fluoro, chloro or bromo.